In:
Future Oncology, Future Medicine Ltd, Vol. 18, No. 39 ( 2022-12), p. 4399-4413
Abstract:
Tweetable abstract Cancer-specific methylation markers combined with the three serum biomarkers (AFP, AFP-L3 and DCP) in a commercial diagnostic test, μTASWako, improve accuracy of liver cancer screening in high-risk populations.
Type of Medium:
Online Resource
ISSN:
1479-6694
,
1744-8301
DOI:
10.2217/fon-2022-1218
Language:
English
Publisher:
Future Medicine Ltd
Publication Date:
2022
Permalink